Oncolytics Biotech Inc. (ONC.TO)
| Previous Close | 1.6900 |
| Open | 1.6600 |
| Bid | 1.5900 x 0 |
| Ask | 1.6100 x 0 |
| Day's Range | 1.5400 - 1.6600 |
| 52 Week Range | 1.2000 - 4.4900 |
| Volume | |
| Avg. Volume | 71,745 |
| Market Cap | 119.917M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.4100 |
| Earnings Date | May 09, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.67 |
Insider MonkeyOncolytics Biotech Inc. (NASDAQ:ONCY) Q1 2024 Earnings Call Transcript
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q1 2024 Earnings Call Transcript May 9, 2024 Oncolytics Biotech Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to Oncolytics Biotech’s First Quarter 2024 Conference Call. [Operator Instructions]. Please be advised […]
- Baystreet
Stocks in play: Oncolytics Biotech Inc
Announces recent operational highlights and financial results for the first quarter ended March 31, ...
PR NewswireOncolytics Biotech® Reports First Quarter 2024 Financial Results and Operational Highlights
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced recent operational highlights and financial results for the first quarter ended March 31, 2024. All dollar amounts are expressed in Canadian currency unless otherwise noted.
